Nectar Lifesciences to consider audited financial results

Nectar Lifesciences Ltd. announced that an adjourned meeting of the Board of Directors is scheduled for July 7, 2025. The primary agenda is to consider and approve the audited financial results for the financial year 2024-25. The meeting will also address the review of the company's financial statements for the same period and related matters. This decision follows an earlier adjournment, as referenced in the company's letter dated May 30, 2025. The announcement was made to comply with Regulations 29, 30, and 33 of the Securities and Exchange Board of India's (Listing Obligations and Disclosure Requirements) Regulations, 2015.